Targeting mitochondrial calcium pathways as a potential treatment against Parkinson’s disease
Open Access
- 1 July 2020
- journal article
- research article
- Published by Elsevier in Cell Calcium
- Vol. 89, 102216
Abstract
No abstract availableKeywords
Funding Information
- Narodowe Centrum Nauki
This publication has 109 references indexed in Scilit:
- MCU encodes the pore conducting mitochondrial calcium currentseLife, 2013
- MCUR1 is an essential component of mitochondrial Ca2+ uptake that regulates cellular metabolismNature Cell Biology, 2012
- The Pathophysiology of LETM1Journal of General Physiology, 2012
- The L-type channel antagonist isradipine is neuroprotective in a mouse model of Parkinson's diseaseNeurobiology of Disease, 2011
- Integrative genomics identifies MCU as an essential component of the mitochondrial calcium uniporterNature, 2011
- A forty-kilodalton protein of the inner membrane is the mitochondrial calcium uniporterNature, 2011
- PINK1-Associated Parkinson's Disease Is Caused by Neuronal Vulnerability to Calcium-Induced Cell DeathMolecular Cell, 2009
- A Mitochondrial Protein Compendium Elucidates Complex I Disease BiologyCell, 2008
- Helical α-Synuclein Forms Highly Conductive Ion ChannelsBiochemistry, 2007
- The plasma membrane Na+/Ca2+exchange inhibitor KB‐R7943 is also a potent inhibitor of the mitochondrial Ca2+uniporterBritish Journal of Pharmacology, 2007